Life sciences teams are under pressure to engage patients more effectively—from trial recruitment through long-term adherence—but new research shows most engagement methods aren’t scalable or built for personalization. Here are the key findings shaping Lirio’s upcoming life sciences market report.
MM+M highlights Lirio as a top AI-powered pharma marketing tool, showcasing how Precision Nudging® drives real patient engagement and behavior change.
New research shows why AI investments aren’t translating into better patient engagement—and how N-of-1 personalization could help health systems close the gap.
Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, is proud to announce its inclusion on the Inc. Best in Business list. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries.
As healthcare moves into our homes, convenience alone isn’t enough. While new technologies make testing and treatment possible at home, real impact depends on how well they fit into everyday lives—supporting motivation, routines, and the meaning we attach to home.
Lirio, the first-ever behavioral science and agentic AI platform that empowers people to live their healthiest lives, today released a report based on in-depth surveys with more than 75 executives from U.S. health systems, independent hospitals, and physician groups, showing more than half of healthcare organizations struggle to customize patient outreach content.